Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Zomedica Pharmaceuticals Corp (ZOM)

Zomedica Pharmaceuticals Corp (ZOM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Zomedica Pharmaceuticals Corp 100 PHOENIX DRIVE SUITE 125 ANN ARBOR MI 48108 USA

www.zomedica.com Employees: 144 P: 734-369-2555

Description:

Zomedica Corp. is a veterinary health company. It creates products for companion animals by focusing on the unmet needs of clinical veterinarians. Zomedica Corp., formerly known as Zomedica Pharmaceuticals Corp., is based in Ann Arbor, Michigan.

Key Statistics

Overview:

Market Capitalization, $K 132,293
Enterprise Value, $K 119,343
Shares Outstanding, K 979,950
Annual Sales, $ 25,190 K
Annual Net Income, $ -34,530 K
Last Quarter Sales, $ 7,000 K
Last Quarter Net Income, $ -6,700 K
EBIT, $ -54,290 K
EBITDA, $ -50,200 K
60-Month Beta 1.06
% of Insider Shareholders 4.19%
% of Institutional Shareholders 8.95%
Float, K 938,890
% Float 95.81%
Short Volume Ratio 0.27

Growth:

1-Year Return -24.00%
3-Year Return -71.82%
5-Year Return -64.94%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 88.89%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.01 on 11/07/24
Next Earnings Date N/A
Earnings Per Share ttm -0.03
EPS Growth vs. Prev Year 247.37%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ZOM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -12.47%
Return-on-Assets % -11.84%
Profit Margin % -137.08%
Debt/Equity 0.00
Price/Sales 5.37
Price/Cash Flow N/A
Price/Book 0.67
Book Value/Share 0.21
Interest Coverage -198.22
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar